Fujian Yuanxiang New MaterialsLtd Inkomsten in het verleden
Verleden criteriumcontroles 3/6
Fujian Yuanxiang New MaterialsLtd's earnings have been declining at an average annual rate of -7.4%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 8.5% per year. Fujian Yuanxiang New MaterialsLtd's return on equity is 4.9%, and it has net margins of 8.5%.
Belangrijke informatie
-7.4%
Groei van de winst
-12.3%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 12.1% |
| Inkomstengroei | 8.5% |
| Rendement op eigen vermogen | 4.9% |
| Nettomarge | 8.5% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Fujian Yuanxiang New MaterialsLtd (SZSE:301300) Will Be Hoping To Turn Its Returns On Capital Around
Sep 30
What Fujian Yuanxiang New Materials Co.,Ltd's (SZSE:301300) 54% Share Price Gain Is Not Telling You
Jul 12Fujian Yuanxiang New MaterialsLtd (SZSE:301300) Is Due To Pay A Dividend Of CN¥0.40
Jun 03Fujian Yuanxiang New Materials Co.,Ltd's (SZSE:301300) Share Price Not Quite Adding Up
Feb 26Opbrengsten en kosten
Hoe Fujian Yuanxiang New MaterialsLtd geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 459 | 39 | 38 | 19 |
| 30 Jun 24 | 451 | 36 | 41 | 18 |
| 31 Mar 24 | 412 | 33 | 40 | 17 |
| 31 Dec 23 | 394 | 34 | 36 | 16 |
| 30 Sep 23 | 373 | 37 | 38 | 14 |
| 30 Jun 23 | 349 | 40 | 30 | 13 |
| 31 Mar 23 | 353 | 48 | 29 | 13 |
| 01 Jan 23 | 367 | 53 | 29 | 13 |
| 30 Sep 22 | 376 | 60 | 20 | 15 |
| 30 Jun 22 | 400 | 68 | 22 | 14 |
| 31 Mar 22 | 403 | 71 | 20 | 13 |
| 01 Jan 22 | 405 | 77 | 19 | 14 |
| 30 Sep 21 | 404 | 83 | 21 | 12 |
| 30 Jun 21 | 392 | 84 | 22 | 12 |
| 31 Mar 21 | 356 | 75 | 21 | 11 |
| 31 Dec 20 | 321 | 66 | 16 | 10 |
| 30 Sep 20 | 297 | 57 | 22 | 9 |
| 30 Jun 20 | 273 | 48 | 29 | 9 |
| 31 Mar 20 | 275 | 46 | 33 | 9 |
| 01 Jan 20 | 277 | 43 | 37 | 9 |
| 01 Oct 19 | 264 | 40 | 37 | 9 |
| 30 Jun 19 | 251 | 37 | 35 | 10 |
| 31 Mar 19 | 249 | 41 | 34 | 9 |
| 01 Jan 19 | 246 | 46 | 34 | 9 |
| 30 Sep 18 | 236 | 43 | 32 | 9 |
| 30 Jun 18 | 226 | 40 | 31 | 9 |
| 31 Mar 18 | 209 | 31 | 28 | 9 |
| 31 Dec 17 | 193 | 22 | 27 | 8 |
| 30 Sep 17 | 185 | 20 | 28 | 6 |
| 30 Jun 17 | 178 | 18 | 30 | 3 |
| 31 Mar 17 | 171 | 18 | 31 | 2 |
| 31 Dec 16 | 165 | 17 | 32 | 0 |
| 30 Sep 16 | 162 | 15 | 31 | 0 |
| 30 Jun 16 | 158 | 11 | 31 | 0 |
| 31 Mar 16 | 156 | 9 | 30 | 0 |
| 31 Dec 15 | 154 | 7 | 30 | 0 |
| 31 Dec 14 | 155 | 12 | 28 | 0 |
| 31 Dec 13 | 144 | 15 | 27 | 0 |
Kwaliteitswinsten: 301300 has high quality earnings.
Groeiende winstmarge: 301300's current net profit margins (8.5%) are lower than last year (10%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 301300's earnings have declined by 7.4% per year over the past 5 years.
Versnelling van de groei: 301300's earnings growth over the past year (4.4%) exceeds its 5-year average (-7.4% per year).
Winst versus industrie: 301300 earnings growth over the past year (4.4%) exceeded the Chemicals industry -3.8%.
Rendement op eigen vermogen
Hoge ROE: 301300's Return on Equity (4.9%) is considered low.